If you have been reading about cyclic heptapeptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
Identity and purity are assessed with chromatographic and mass spectrometric techniques. Reversed-phase high-performance liquid chromatography separates the target peptide from related impurities and degradation products, and the resulting retention time is compared against a reference standard. Mass spectrometry, often coupled to liquid chromatography, confirms molecular mass. Amino acid analysis or peptide mapping can provide additional sequence-level confirmation when required. Results are only as reliable as the reference materials used alongside them.
Regulatory treatment varies by country. In the United States, melanotan-2 is not approved for any indication, and products marketed for human use fall outside the approved drug framework. Some other jurisdictions have placed it under prescription controls or listed it as a prohibited or restricted substance. Online listings frequently describe the material as a research chemical, a category that does not carry the same manufacturing and labelling requirements as approved medicines.
Solid peptide material is generally stable when kept cold and dry. Common practice is storage at -20 degrees Celsius or lower, with desiccant and protection from light. Repeated freeze-thaw cycles and exposure to moisture are associated with degradation, aggregation, or loss of material. Once dissolved, stability depends on solvent, concentration, and temperature, and solutions are usually treated as short-lived unless stability data support longer periods. Handling notes typically emphasise minimising time at ambient temperature.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic cyclic heptapeptide | Analog of alpha-MSH with an internal lactam bridge |
| Molecular weight | Approximately 1024 daltons | Free base value; salt forms differ |
| Appearance | White to off-white powder | Usually supplied as a lyophilized solid |
| Solubility | Freely soluble in water | Poorly soluble in nonpolar solvents |
| Typical storage | −20 °C, dry, protected from light | Repeated freeze-thaw cycles degrade peptides |
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
Regulatory status varies by jurisdiction, and the substance is frequently described as unapproved for therapeutic use. Some authorities classify it alongside prescription-only medicines or controlled categories, while others address it through general consumer protection rules. Analytical surveys have reported mismatches between label claims and measured content in products sold online, although the scope of such testing is limited. Whether these discrepancies are widespread remains an open question. Discussion in the literature therefore tends to combine chemistry, supply-chain observation and policy analysis.
The material is commonly handled as a lyophilized powder in sealed vials. The solid dissolves readily in water and in polar organic solvents, producing a clear solution after reconstitution. Light, heat and repeated freeze-thaw cycles are the concerns most often raised in handling guidance, because peptide bonds and the constrained ring can degrade. Working solutions are generally prepared fresh, and material left in solution is treated as less stable than the dry form. These properties shape how laboratories store and aliquot reference material.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
Identification in laboratories relies on reversed-phase liquid chromatography coupled with tandem mass spectrometry, with product-ion spectra compared against a certified reference standard. High-resolution mass spectrometry supplies accurate mass confirmation, and peptide mapping after enzymatic digestion separates melanotan II from closely related analogues. Quantitation of seized material is complicated by unknown counter-ions and residual trifluoroacetate left from purification. Immunoassays raised against alpha-melanocyte-stimulating hormone can cross-react, so chromatographic confirmation is normally required. Urinary detection windows are short, and reported limits of detection differ substantially between laboratories.
Melanotan II holds no marketing authorisation from the Food and Drug Administration, the European Medicines Agency, the UK Medicines and Healthcare products Regulatory Agency or Australia's Therapeutic Goods Administration. Products sold under that name are treated as unapproved new drugs, and their sale or import is prohibited in several jurisdictions. Other countries classify the peptide as a prescription-only medicine or place it among controlled substances, so the legal position changes with the destination market. No pharmacopoeial monograph supplies an official specification, because the material is not a licensed pharmaceutical. Consequently, products offered online are not manufactured to a shared public standard.
The peer-reviewed record is dominated by small early-phase studies, case reports and pharmacovigilance summaries rather than large randomised trials. Papers typically examine tanning response, receptor selectivity or patterns of reported adverse events. Many note that participants obtained the peptide outside a clinical setting, which limits verification of composition and administered amount. Reported events vary widely, and causality is frequently unclear because the identity and purity of self-sourced material are unknown. Open questions include whether repeated melanocortin receptor stimulation produces cumulative effects, and how often label claims match actual content.
==== Mining and extraction of fuels ==== According to the World Nuclear Association, coal from all deposits contains traces of various radioactive substances, particularly radon, uranium and thorium. These substances are released during coal mining, especially from surface mines, through power plant emissions, or power plant ash, and contribute to terrestrial radiation exposure through their exposure pathways. In December 2009, it was revealed that oil and gas production generates millions of tons of radioactive waste each year, much of which is improperly disposed of without detection, including 226Radium and 210Polonium. The specific activity of the waste ranges from 0.1 to 15,000 becquerels per gram. In Germany, according to the Radiation Protection Ordinance of 2001, the material is subject to monitoring at one Becquerel per gram and would have to be disposed of separately. The implementation of this regulation has been left to the industry, which has disposed of the waste carelessly and improperly for decades.
=== Working standards === Primary, calibration, and reference materials are only available in small quantities and purchase is often limited to once every few years. Depending on the specific isotope systems and instrumentation, a shortage of available reference materials can be problematic for daily instrument calibrations or for researchers attempting to measure isotope ratios in a large number of natural samples. Rather than using primary materials or reference materials, a laboratory measuring stable isotope ratios will typically purchase a small quantity of the relevant reference materials and measure the isotope ratio of an in-house material against the reference, making that material into a working standard specific to that analytical facility. Once this lab-specific working standard has been calibrated to the international scale the standard is used to measure the isotopic composition of unknown samples. After measurement of both sample and working standard against a third material (commonly called the working gas or the transfer gas) the recorded isotopic distributions are mathematically corrected back to the international scale. It is thus critical to measure the isotopic composition of the working standard with high precision and accuracy (as well as possible given the precision of the instrument and the accuracy of the purchased reference material) because the working standard forms the ultimate basis for accuracy of most mass spectrometric observations.
==== Germany ==== In Germany all of the major parties are loosely associated with research foundations that play some role in shaping policy, but generally from the more disinterested role of providing research to support policymakers than explicitly proposing policy. These include the Konrad-Adenauer-Stiftung (Christian Democratic Union-aligned), the Friedrich-Ebert-Stiftung (Social Democratic Party-aligned), the Hanns-Seidel-Stiftung (Christian Social Union-aligned), the Heinrich-Böll-Stiftung (aligned with the Greens), Friedrich Naumann Foundation (Free Democratic Party-aligned) and the Rosa Luxemburg Foundation (aligned with Die Linke). The German Institute for International and Security Affairs is a foreign policy think tank. Atlantic Community is an independent, non-partisan and non-profit organization set up as a joint project of Atlantische Initiative e.V. and Atlantic Initiative United States. The Institute for Media and Communication Policy deals with media-related issues. Transparency International is a think tank on the role of corporate and political corruption in international development.
==== Physical infrastructure ==== The destruction of physical infrastructure has represented high costs for several sectors of the economy, directly altering production and distribution networks. The costs generated by damage to the oil infrastructure have shown a substantial increase since 1990. This is mainly explained by the increase in attacks on oil pipelines by groups outside the law. According to data from Ecopetrol, between 1999 and 2003, the costs assumed by the hydrocarbon exploitation sector grew by approximately 59%, amounting to $817,654.5 million. This equates to 23.6% of the total royalties that Ecopetrol turned to 20 departments and 110 municipalities, destined to improve the quality of life of the inhabitants. For 2004, costs decreased substantially to $11,015.5 million. This is the first sector most affected by the terrorist actions of groups outside the law. The costs are mainly derived from the spilled oil, "[...] from the repair of the pipeline, from the environmental decontamination and from the oil stopped producing 60% of the total expenses incurred." During the 1999–2003 period, costs against electrical and telecommunications towers increased substantially, representing $134,871.2 million. This is equivalent to 5.4% of 2003 GDP for the electricity, gas, and water sector. On the other hand, according to data from the National Institute of Roads (INVÍAS), between 1993 and 1995, groups outside the law demolished 11 tolls and a bridge, and its reconstruction cost $378,476,248.
Sources: en.wikipedia.org
Matrix-assisted laser desorption ionization can be used as a mass spectrometry imaging technique for relatively large molecules. It has recently been shown that the most effective type of matrix to use is an ionic matrix for MALDI imaging of tissue. In this version of the technique the sample, typically a thin tissue section, is moved in two dimensions while the mass spectrum is recorded. Although MALDI has the benefit of being able to record the spatial distribution of larger molecules, it comes at the cost of lower resolution than the SIMS technique. The limit for the lateral resolution for most of the modern instruments using MALDI is 20
=== Pharmacokinetics === 1,2-Diarylethylamines are generally lipophilic, allowing for extensive tissue distribution, particularly in adipose tissue. For example, diphenidine has been found at concentrations exceeding 11,000 ng/g in fat tissue during postmortem analysis. These compounds are typically active via oral and parenteral routes, with exposure ranging from 3 to 8 hours depending on the compound and dosage. Metabolism primarily occurs via hepatic cytochrome P450 enzymes, including CYP1A2, CYP2B6, CYP2C9, CYP2C19, and CYP3A4, leading to hydroxylated, dealkylated, and oxidized metabolites. Phase II conjugation processes such as glucuronidation and sulfation also occur. Metabolites are excreted in urine and have been detected in both clinically and in forensic settings.
=== Specific === Acetylcysteine Atropine Calcium gluconate Methylthioninium chloride (methylene blue) Naloxone Penicillamine Potassium ferric hexacyano-ferrate(II) -2H2O (prussian blue) Sodium nitrite Sodium thiosulfate Complementary:
In contrast to the general similarity in structure and function of the electron transport chains in eukaryotes, bacteria and archaea possess a large variety of electron-transfer enzymes. These use an equally wide set of chemicals as substrates. In common with eukaryotes, prokaryotic electron transport uses the energy released from the oxidation of a substrate to pump ions across a membrane and generate an electrochemical gradient. For bacteria, oxidative phosphorylation is understood in most detail in Escherichia coli, while archaeal systems are, at present, poorly understood. The main difference between eukaryotic and prokaryotic oxidative phosphorylation is that bacteria and archaea use many different substances to donate or accept electrons. This allows prokaryotes to grow under a wide variety of environmental conditions. In E. coli, for example, oxidative phosphorylation can be driven by a large number of pairs of reducing agents and oxidizing agents, which are listed below. The midpoint potential of a chemical measures how much energy is released when it is oxidized or reduced, with reducing agents having negative potentials and oxidizing agents positive potentials.
24 March – Avanti West Coast is to increase the fee for an overtime shift for its drivers by 380% following a deal with train drivers' union ASLEF. 26 March Pizza retailer Papa John's announces the closure of 43 of its 450 UK outlets. The High Court of Justice grants WikiLeaks founder Julian Assange a stay of extradition to the United States, and demands that the US not consider the death penalty against Assange if he is sent to the US to face espionage charges. 27 March – Provisional figures from the Home Office indicate that 4,644 migrants have crossed the English Channel in boats during the first three months of 2024. 28 March – BBC News publishes details of a 2016 draft report that implies the Post Office knew its defence case in the Horizon IT scandal was false, and that it had not made full disclosure to defendants. 29 March Sir Jeffrey Donaldson resigns as leader of the Democratic Unionist Party after being charged with rape and other historical sexual offences. Gavin Robinson is appointed interim leader until a new leader can be elected. Pouria Zeraati, an anti-Iranian regime journalist working for Iran International, is stabbed by a group of people in London. He is taken to hospital, where he is in stable condition. 30 March First Minister of Northern Ireland Michelle O'Neill says she is determined the Stormont Assembly and Executive will continue to function following the resignation of Jeffrey Donaldson as DUP leader.
Sources: en.wikipedia.org
It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.
Melanotan-1, also called afamelanotide, is a shorter linear analog with a different amino acid sequence and no lactam ring. It has been evaluated in formal clinical programs, while melanotan-2 has not. The two are distinct molecules and are not interchangeable.
No. Bremelanotide is a related but distinct cyclic peptide that reached approved status for one specific clinical indication. Melanotan-2 is a separate molecule with its own sequence and properties. Shared ancestry in the melanocortin family does not make them the same substance.
Laboratory confirmation typically combines retention time matching on a chromatographic system with mass measurement. A reference standard of known identity is needed for a meaningful comparison. Sequence-level techniques can add further confirmation.